Zeriscope wins army contract to support TBI treatment research

1 December 2017 (Last Updated December 1st, 2017 11:14)

US-based company Zeriscope has secured a new army contract to provide assistance in a study that would help mitigate the effects of traumatic brain injury (TBI).

US-based company Zeriscope has secured a new army contract to provide assistance in a study that would help mitigate the effects of traumatic brain injury (TBI).

The contract has been awarded by the Army Advanced Medical Technology Initiative (AAMTI).

Zeriscope is a mobile telemedicine platform company that facilitates live, secure, online, video-enabled telemedicine exams.

The real-time streaming telemedicine platform of the company is being used along with its integrated wearable sensor kit to monitor heart rate variability (HRV), a biomarker associated with the ability to regulate the autonomic nervous system, attentiveness and emotional responses.

Zeriscope’s wearable physiological devices can be used to monitor and study the HRV in out-of-the-laboratory settings.

“We’re very proud to have been selected by the Army to assist in this important and advanced research on TBI.”

This will help enhance research and the understanding of treatment options for the critical brain injury that impacts several army personnel who have served the nation in combat zones.

Zeriscope chief executive officer Bill Harley said: “We’re very proud to have been selected by the Army to assist in this important and advanced research on TBI.

“Zeriscope’s easy-to-use and cost-effective telemedicine technology is recognised as a smart solution for a broad variety of innovative telemedicine scenarios, leveraging remote medical experts anywhere, anytime.”

The AAMTI study, which will continue for one year, has been designed to gain more knowledge about the effects of various treatment options that would improve outcomes for the personnel impacted by TBI.